Legal & General Group’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $322K | Buy |
10,989
+2,247
| +26% | +$65.9K | ﹤0.01% | 2550 |
|
|
2025
Q1 | $225K | Hold |
8,742
| – | – | ﹤0.01% | 2594 |
|
|
2024
Q4 | $252K | Buy |
8,742
+7,654
| +703% | +$221K | ﹤0.01% | 2636 |
|
|
2024
Q3 | $25.8K | Hold |
1,088
| – | – | ﹤0.01% | 2948 |
|
|
2024
Q2 | $18.8K | Buy |
1,088
+706
| +185% | +$12.2K | ﹤0.01% | 3047 |
|
|
2024
Q1 | $8.53K | Hold |
382
| – | – | ﹤0.01% | 3233 |
|
|
2023
Q4 | $7.01K | Hold |
382
| – | – | ﹤0.01% | 3281 |
|
|
2023
Q3 | $6.64K | Hold |
382
| – | – | ﹤0.01% | 3336 |
|
|
2023
Q2 | $6.96K | Buy |
+382
| New | +$6.96K | ﹤0.01% | 3355 |
|
|
2022
Q2 | – | Sell |
-404
| Closed | -$14K | – | 3679 |
|
|
2022
Q1 | $14K | Buy |
404
+187
| +86% | +$6.48K | ﹤0.01% | 3328 |
|
|
2021
Q4 | $19K | Hold |
217
| – | – | ﹤0.01% | 3297 |
|
|
2021
Q3 | $25K | Buy |
+217
| New | +$25K | ﹤0.01% | 3200 |
|